Reata Pharmaceuticals Inc. logo

Reata Pharmaceuticals Inc.

RETA | NASDAQ
Chart Builder DCF Calculator
$172.36
+$0.04 (+0.02%)
At close: Sep 25, 2023, 04:00 PM ET

Market Data

Market Cap
$6.57B
Enterprise Value
$6.4B
Beta
1.42
Average Volume
N/A
Shares Outstanding (Diluted)
41.51M
Shares Change YoY
13.82%
Institutional Ownership
N/A
Exchange
N/A
ISIN
N/A

Price Performance

Price Change 1M
N/A
Price Change 3M
N/A
Price Change 6M
N/A
Price Change YTD
N/A
Price Change 1Y
N/A
Price Change 3Y
N/A
Price Change 5Y
N/A
1M CAGR (ann.)
1.8%
1Y CAGR (ann.)
679.2%
5Y CAGR (ann.)
14.5%
All-Time CAGR
42.1%

Valuation

PE Ratio
-61.56
Forward PE
N/A
PEG Ratio
-0.38
Forward PEG
-0.38
PS Ratio
269.17
Forward PS
N/A
PB Ratio
75.22
P/FCF Ratio
-26.32
P/Adj. FCF Ratio
-19.47
P/OCF Ratio
-30.67
EV/Sales
262.44
EV/EBIT
-94.37
EV/EBITDA
-62.49
EV/FCF
-25.66
Earnings Yield
-1.6%
FCF Yield
-3.8%
Adj. FCF Yield
-5.1%

Financial Health

Net Cash
$237.34M
Total Debt
$166M
Cash & Short-Term Investments
$330.21M
Total Assets
$502.59M
Current Ratio
6.75
Quick Ratio
6.75
Debt / Equity Ratio
-1.82
Debt / EBITDA
-1.62
Debt / FCF
-0.67
OCF / Debt
-1.50
Interest Coverage
-6.47
Altman Z-Score
5.75
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-243.8%
EBITDA Margin
-12140.1%
Net Profit Margin
-14075.0%
FCF Margin
-1022.6%
Adj. FCF Margin
-1382.7%
SBC / Revenue
2650.3%
SBC Impact (per share)
-35.2%

Returns

Return on Assets
-60.6%
Return on Equity
47.2%
Return on Invested Capital
-59.0%
Return on Capital Employed
-59.3%
Return on Tangible Assets
-60.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
16.7%
Revenue CAGR 5Y
-17.1%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
39.0%
EPS CAGR 5Y
7.2%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-20.4%
FCF CAGR 5Y
-6.2%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
10
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Aug 4, 2024
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$62.67
Price Target Upside
-63.6%

Cash Flow

Operating Cash Flow
$-248.34M
Free Cash Flow
$-249.46M
Adj. Free Cash Flow
$-337.3M
FCF Per Share
-$5.71
OCF Per Share
-$5.62
OCF/S Ratio
-9217.8%

Income Statement

Revenue
$24.4M
Gross Profit
$23.55M
Operating Income
$-59.48M
EBITDA
$-102.46M
Net Income
$-80.06M
EPS (Diluted)
-$2.80
Revenue / Employee
N/A
Profit / Employee
N/A
Employees
N/A

© 2026 bestshares.com. All rights reserved.